Help Heal
Your Skin
From Within

DUPIXENT treats people 12 years of age and older with moderate-to-severe atopic dermatitis that is not well controlled with topical prescription therapies.

Learn About DUPIXENT
Jason,
Real patient. Individual results may vary.
Shawn,
Real patient. Individual results may vary.

First biologic treatment of its
kind to help continously treat
moderate-to-severe eczema.

Helps manage the inflammation deep
beneath the surface that contributes
to the flare-ups on the skin

Twice monthly injectable
prescription medicine that is
not a steroid or cream


DUPIXENT May Be Right For You

DUPIXENT was studied in adults and teens ages 12-17. See the clinical results by choosing adults or teens.

For Adults (Ages 18+)

DUPIXENT was studied in 3 clinical trials with more than 2,100 adults with moderate-to-severe eczema not well controlled with topical prescription treatments. It was first approved by the FDA on March 28, 2017.

View Results in Adults Jennifer,
Real patient. Individual results may vary.

For Teens (Ages 12-17)

DUPIXENT was studied in a 16-week clinical trial with 251 patients ages 12-17 with moderate-to-severe eczema not well controlled with topical prescription treatments. It was approved by the FDA for this patient population on March 11, 2019.

View Results in Teens Noah,
Real patient. Individual results may vary.

DUPIXENT MyWay® Copay Card

The DUPIXENT MyWay Copay Card may help covering the cost of DUPIXENT. If you’re eligible, you can sign up and download your copay card on the site.

See Copay Details

DUPIXENT MyWay also offers Nurse Educator Support, supplemental injection training online or in-person, and more.

See more information

Real Patient Experiences

Everyone has a story to tell. Hear from DUPIXENT
ambassadors as they share their messages and
lessons they’ve learned.

Hear Their Stories

Shawn,
Real patient. Individual results may vary.

Find a Specialist Who
Treats Eczema

Use this Healthgrades™ tool to easily find nearby specialists with experience in treating teens and adults with uncontrolled moderate-to-severe eczema (atopic dermatitis).